D
DeepHealth
DeepHealth (Formerly Aidence) is improving healthcare using Computer-Aided Diagnostics
About DeepHealth
Aidence is a pioneering startup specializing in artificial intelligence (AI) solutions for the oncology pathway, particularly focusing on lung cancer diagnosis and management. The company has developed the Veye suite of medical imaging AI applications, which are designed to seamlessly integrate into existing radiology workflows. This suite includes Veye Lung Nodules, an automated lung nodule management assistant that aids radiologists in detecting and quantifying lung nodules on chest CT scans. The Veye applications are CE certified, ensuring they meet European health, safety, and environmental protection standards.
Read full description
Aidence primarily serves healthcare providers, including hospitals and clinics, with a notable presence in the United Kingdom and the Netherlands. The company collaborates with prominent institutions such as the NHS England and has partnered with pharmaceutical giant AstraZeneca to support early lung cancer diagnosis using AI technology.
Operating in the medical imaging and healthcare technology market, Aidence employs a business-to-business (B2B) model. It generates revenue by licensing its AI applications to healthcare providers and institutions. These clients benefit from improved diagnostic accuracy and efficiency, which can lead to better patient outcomes and streamlined workflows.
Aidence's innovative approach combines deep learning algorithms with the expertise of clinical specialists to create solutions that are both effective and user-friendly. By integrating directly into Picture Archiving and Communication Systems (PACS), Aidence ensures that its tools are easily accessible to radiologists during their routine clinical practice and lung cancer screening programs.
In summary, Aidence is at the forefront of leveraging AI to enhance the oncology pathway, providing valuable tools to healthcare providers for early and accurate lung cancer diagnosis.
At a glance
- Status
- Acquired
- Founded
- 2015
- Headquarters
- Amsterdam, Netherlands
- Employees
- 13
- Open positions
- None listed
- Dealroom signal
- 61.5/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Oncology, Radiology, Medical Imaging, Core AI, Health Diagnostics, EIC
- Technology
- Artificial Intelligence, Big Data, Machine Learning, Computer Vision
- Business model
- SaaS
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITION✓Exit | Jan 2022 | $0 | — | RadNet | ↗ |
| GRANT✓Other financing | Mar 2020 | $1.9M | — | European Innovation Council | — |
Growth signals
Latest recorded traffic for DeepHealth is 2K monthly website visits, down 60.8% over the last three months. DeepHealth's team declined 45.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed5 investors entered at this stage
NLC Health Ventures
henQ
Health Innovations
Northzone
European Innovation Council
Series A3 investors entered at this stage
Rabo Ventures
Rabo Frontier Ventures
Inkef
Other known investors3 additional known investors
RadNet
Rabo Food & Agri Innovation Fund
Rabo Investments
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about DeepHealth on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See DeepHealth’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.